Effects of exercise and lovastatin on serum creatine kinase activity. 1991

P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
Department of Medicine, Miriam Hospital, Providence, RI 02906.

Vigorous physical activity and lovastatin (Mevacor) a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, have both been independently associated with elevated creatine kinase (CK) levels. To determine the effect of lovastatin plus exercise on serum CK activity, we measured CK levels before and after maximal treadmill exercise in 14 men (51.6 +/- 17.3 years, mean +/- SD) and 6 women (48.5 +/- 7.4 years) before and after 4 weeks of lovastatin treatment (20 mg/d). Blood samples were obtained before, immediately after, and 24 hours after exercise. Individual subjects were exercised for the same duration on each test. Preexercise CK levels and the average CK response to treadmill exercise did not differ before and after lovastatin treatment. In two men taking lovastatin, however, CK levels increased by 183% and 242% 24 hours after exercise during lovastatin administration. We conclude that low-dose lovastatin treatment plus exercise does not affect average CK activity but that this combination may markedly increase CK levels in certain individuals.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
January 1999, The American journal of Chinese medicine,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
August 1965, British medical journal,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
July 1965, British medical journal,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
October 1976, Archives of general psychiatry,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
January 1985, European journal of applied physiology and occupational physiology,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
June 1965, British medical journal,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
January 1981, Enzyme,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
January 1971, Biology of the neonate,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
August 1983, Clinica chimica acta; international journal of clinical chemistry,
P D Thompson, and P A Gadaleta, and S Yurgalevitch, and E Cullinane, and P N Herbert
August 1996, Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering,
Copied contents to your clipboard!